Archive for the ‘Bartonella’ Category

May 3, 2023 Tick Boot Camp Podcast: Eva Sapi, PhD

https://tickbootcamp.com/eva-sapi-geneticist-and-molecular-biologist-at-university-of-new-haven/

Eva Sapi, Geneticist And Molecular Biologist At University Of New Haven

Eva Sapi

Tick Boot Camp Podcast
Dr. Michael Snyder was featured on the Tick Boot Camp Podcast:

Launching May 3…

Background
Professor Eva Sapi is a Hungarian-American microbiologist and researcher who has dedicated her career to advancing our understanding of Lyme disease.

Early Life and Career
Born in Hungary, Sapi comes from a family of engineers and scientists. She studied biology at a university in Hungary from 1987 to 1995 and earned her Ph.D. in biology from the same university. She went on to complete postdoctoral work in Germany and Switzerland, where she focused on studying gene regulation in bacteria, and understanding how genes are turned on and off in response to environmental cues.

Early Research
Professor Sapi started her research career studying breast cancer until she was hit with chronic Lyme disease and it paused her life. After finally getting a proper Lyme diagnosis and spending years trying many different pharmaceutical and herbal treatments, Sapi began to feel better and started collecting and studying ticks. She discovered that ticks carry Bartonella and that ticks could carry many different species of bugs that can infect humans, which was not received well by the medical community at the time.

Official Lyme Career Pivot
Next, Professor Eva Sapi joined the University of New Haven in Connecticut as an Associate Professor in the Department of Biology and Environmental Science. She was also appointed as the Director of the Lyme Disease Research Group at the university, where she continued her research on Lyme disease and other tick-borne illnesses.

Popular Work
Sapi is known for her groundbreaking research on the persistence and treatment of Lyme disease. She was the first to discover that Borrelia burgdorferi can form biofilms that protect it from antibiotics and the immune system. Her current research, with James Goldman, a Columbia University professor of pathology and cell biology, centers on a case in which a woman received 16 years of antibiotic therapy and still died from Lyme disease. Their findings – published in Healthcare 2018 – supported her earlier discoveries that Borrelia can form biofilm, a protective layer around itself, making it extremely resistant to antibiotics.

Notable Achievements
Professor Sapi has authored 70 peer-reviewed scientific papers on Lyme disease and trained more than 100 graduate students in Lyme disease research. She is a sought-after speaker and presenter and has appeared on radio and television programs. Her groundbreaking research has earned her several recognitions, including the research trailblazer award from LymeDisease.org in 2018, and the Courage Award from Lyme Connection of Ridgefield. Her ultimate goal is to identify novel antibacterial agents that are effective in killing all forms of Borrelia.

Recent Breakthroughs
Sapi’s research has also shown that some herbal remedies, such as Stevia, can be effective in treating Lyme disease. Her recent breakthrough, with her students, is in the potential of liquid, whole-leaf Stevia extract in reducing biofilm mass. In a recent study, they found that liquid, whole-leaf Stevia extract is an effective treatment for Lyme biofilm. This finding is significant because Borrelia biofilm is a protective layer around itself, making it extremely resistant to antibiotics.

Lyme and Cancer
Sapi’s research has also found evidence that Borrelia may be present in breast cancer tissues, as well as ovarian and endometrial cancer. She and her students are focusing on Borrelia, examining more than 400 invasive breast cancer tissues. A significant number of samples were positive for Borrelia, suggesting that the bacteria may play a role in breast cancer development and metastasis.

Looking Ahead
Professor Eva Sapi’s work on breast cancer and its link to Lyme disease has opened new avenues for research and has the potential to lead to novel discoveries in the field. The scientific community and the Lyme disease community are fortunate to have such a dedicated and passionate researcher leading the charge in advancing Lyme disease research, including its role in cancer.

Listen on Apple Podcasts, Spotify, or Google Podcasts

Listen on Apple Podcasts
Listen on Spotify
Listen on Google Podcasts

Methylene Blue for Lyme & Bartonella (Also COVID)

https://www.treatlyme.net/guide/methylene-blue-for-lyme-and-bartonella  Video Here

Methylene Blue for Lyme and Bartonella: The Ins and Outs

By Dr. Marty Ross

Methylene Blue for Lyme and Bartonella Persisters

The Ins and Outs of Methylene Blue

Methylene blue is a repurposed drug used to treat persister Lyme (Borrelia) and Bartonella. There is also lab evidence showing it treats growing Bartonella. It likely kills growing Lyme too. While methylene blue may treat growing germs, the main reason to use it in Lyme or Bartonella infectious is to treat persisters.

In this video article, Marty Ross, MD discusses the ins and outs, including risks factors, of using methylene blue. Below the video, you can find sample antibiotic protocols for Lyme and Bartonella that include methylene blue.

Notice-How to Use This Article

Be aware, most of the important information in this article is in the video in the top link

(See link for article and video)

______________

**Comment**

Methylene blue, like DMSO and ozone are more like therapeutic principles than drugs and work for many disease processes including COVID, yet mainstream medicine & media is remarkably silent because these safe, cheap, effective alternatives interfere with their conflicts of interest.  The same can be said for ivermectin and HCQ/zinc, as well as long-term antibiotics for Lyme/MSIDS sufferers who continue to have symptoms.

For more:

For more on Bartonella treatment:

For more on MB for COVID:

  • https://www.nature.com/articles/s41598-021-92481-9  MB displays broad-spectrum virucidal activity in the presence of UV light and inactivates various viruses in blood products prior to transfusions.  It’s validated for treating methemoglobinemia and malaria.  Our findings reveal that methylene blue displays virucidal preventive or therapeutic activity against influenza virus H1N1 and SARS-CoV-2 at low micromolar concentrations and in the absence of UV-activation. We also confirm that MB antiviral activity is based on several mechanisms of action as the extent of genomic RNA degradation is higher in presence of light and after long exposure. Our work supports the interest of testing methylene blue in clinical studies to confirm a preventive and/or therapeutic efficacy against both influenza virus H1N1 and SARS-CoV-2 infections.
  • https://biomedres.us/pdfs/BJSTR.MS.ID.006723.pdfSeven outpatients with confirmed cases of severe COVID-19 received oral MB (the reduced form: 1mg/kg T.I.D. for 2-days, followed by 1mg/kg B.I.D. for the next 12 days) along with standard care. Outpatients recovered completely.  Considering all properties of MB such as anti-viral, antibiotic, anticoagulant, immunomodulatory, antioxidants, anti-hypoxemia, and anti-respiratory; it could be applied as an adjunct therapy along with standard care protocols in the clinical management of COVID-19 outpatients. MB is a cheap and FDA-approved drug for methemoglobinemia.
  • https://www.news-medical.net/news/20220325/Study-finds-methylene-blue-is-a-low-micromolar-inhibitor-of-the-the-SARS-CoV-2-spike-protein-and-ACE2-interaction.aspx  Authors of this study revealed that MeBlu is a low‐micromolar inhibitor of the PPI that suppresses interaction between the S protein of SARS-CoV-2 and its cognate receptor ACE2. The dye was also found to be effective against the Delta variant and to suppress virus replication in Vero E6 cells. Scientists believe that MeBlu could be used as an inexpensive drug for the treatment of SARS-CoV-2 infection.
  • https://clinicaltrials.gov/ct2/show/NCT04933864  Since methylene blue can work as a photosensitizer, photodynamic therapy as an antiviral treatment has great potential in the treatment of COVID-19. (The study is ongoing so results are yet to be known)
  • https://pubmed.ncbi.nlm.nih.gov/34019535/  The addition of MB to the treatment protocols significantly improved SpO2 and respiratory distress in COVID-19 patients, which resulted in decreased hospital stay and mortality.
  • https://www.frontiersin.org/articles/10.3389/fphar.2020.600372/full  Screening of our organic dye-based library identified MeBlu as a low-micromolar inhibitor of the interaction between SARS-CoV-2 spike protein and its cognate receptor ACE2, a PPI that is the first critical step initiating the viral entry of this coronavirus. While MeBlu shows strong polypharmacology and might be a somewhat promiscuous PPI inhibitor, its ability to inhibit this PPI could contribute to the antiviral activity of MeBlu against SARS-CoV-2 even in the absence of light making this inexpensive and widely available drug potentially useful in the prevention and treatment of COVID-19 as an oral or inhaled medication.
  • https://www.sciencedirect.com/science/article/pii/S0753332221008064  Currently, the treatment of COVID-19 involves use of antiviral and anti-cytokine drugs. However, both the drugs have low efficacy because they cannot inhibit the production of free radicals and cytokines at the same time. Recently, some researchers have reported the use of methylene blue(MB) in COVID-19 management. MB has been used since a long time as a therapeutic agent, and has been approved by the US FDA for the treatment of other diseases. The additional advantage of MB is its low cost. MB is a safe drug when used in the dose of < 2 mg/kg. In this review, the applicability of MB in COVID-19 and its mechanistic aspects have been explored and compiled. The clinical studies have been explained in great detail. Thus, the potential of MB in the management of COVID-19 has been examined.  The results are satisfactory and provide a ray of hope in this direction. Thus, MB can be termed as a “rescue magic bullet” for COVID-19 treatment. However, for MB administration, meticulous consideration of the dosage is necessary to prevent any untoward effects. MB can be administered thrice orally at a dose of 2–3 mg/kg per day for 7–10 days in newly infected COVID-19 patients. However, this needs to be further studied, and finding the optimal dosage should be the objective of clinical study [43]. The use of MB in novel dosage forms like an anti-COVID mouthwash may also be beneficial [77].  **Warning** MB can interact with antidepressants (selective serotonin reuptake inhibitors and MAO inhibitors) to cause sever toxicity of serotonin.  It also has been found to interact with with dapsoneto form hydroxylamine, which oxidizes hemoglobin and may cause hemolysis [84]. Also, MB is contraindicated in patients with severe renal insufficiency. The use of MB in patients with G6PD deficiency can be detrimental, as it may cause severe hemolysis [53]. In such cases, the use of vitamin B12 and ascorbic acid has proven to be beneficial [85][86][87]. Additionally, concomitant use of NSAIDs may block the bradykinin activity pathways. Thus, NSAIDs may add benefit to MB therapy in COVID-19 [64][88].

When Treating Bartonella Clears Symptoms of Autism, What Next?

https://www.lymedisease.org/when-treating-bartonella-clears-autism/

When treating Bartonella clears symptoms of autism, what next?

By Debbie Kimberg

March 14, 2023

My 16-year-old autistic son’s learning disabilities suddenly resolved after treatment for congenital Bartonella and Lyme infections. (See: After 80% improvement in autism symptoms, he’s going to college.) This turn of events totally shocked our family and left us scrambling to figure out our next steps.

Before beginning treatment for Bartonella, Sammy had a tutor named Annie. This sweet, patient young woman came weekly to our home to help him organize his work and make sure he turned it in.

A few months after starting treatment, Sammy began resisting Annie’s assistance. He’d routinely exclaim, “Mom, I don’t need her help! I’m doing fine by myself!”

At first, I thought his angry behaviors were resurfacing. But then I paid closer attention to his grades and realized that he was right. My son, who had suffered with learning differences and ADHD, could suddenly do his schoolwork with no support from anyone else.

Not only did his ADHD resolve, but his grades in his core classes moved from Cs to As. What a baffling and exciting time for our family!

Learning new words

Concurrently, Sammy began asking me the meaning of all kinds of words. They were words that you would expect a 16-year-old to know, such as tremor, simmer, and immature. With Sammy’s new desire to broaden his vocabulary, we played a word game, though we never called it that.

I deliberately began to speak using larger, more advanced words, coyly embedding the meaning into the sentence to ensure he understood it. Interestingly, he was quick to try to incorporate that same word into conversation to showcase his mastery. He was a sponge! Sammy smiled proudly when he spoke, as he skillfully used a new word in a conversation.

Our vocabulary game reminded me of Forrest Gump running from the school bullies who chased him and how the braces fell off Forrest’s legs and onto the dirt road. It was as if a similar shackle on Sammy’s brain had inhibited his learning. Once it was removed, his ability to learn was remarkable.

Nurturing a new stage in learning

Before, our job as parents had involved helping him get his high school technical diploma (targeted to special education students). Now, we needed to help him catch up on all of the learning he had clearly missed due to this disease and the brain inflammation it caused. Our hope was for him to earn a full high school diploma.

This was uncharted territory.

We believed that a private school would be better equipped to handle his new, unique learning needs. But how could I even begin to explain to a school administrator what had happened, and Sammy’s unusual learning needs?

Although I thought it would be a strange conversation to have, I expected that admissions officers would be supportive and want to work with us. Instead, school after school turned us away, even ones whose mission was to support children with learning differences. Sammy’s diagnosis of autism and his previous IQ and psychological testing didn’t meet the schools’ minimum requirements.

I grew more frustrated as every school that we pursued turned us away. I was at a loss for how to help him.

Then I had an epiphany! A different and potentially better path was needed.

Changing educational gears

Since Sammy was doing well in high school, no longer requiring special education classes and wanting to attend a four-year university, we changed gears. Now, we set our sights on what he needed to learn to take his ACT and be accepted to college. We hoped to leapfrog Sammy to a new level.

This decision turned out to be a great one. A highly regarded college-testing prep school heard what had happened and were eager to help. The owner took an immediate interest in our story and moved Sammy to the top of their long wait list.

Sammy’s ACT tutor was a perfect fit – smart, fun, compassionate—and he loved singing too. Typically, a student would receive private college test prep tutoring for 2-3 months. Sammy received weekly tutoring for 10 months. With the help of this amazing school and its staff, Sammy did well enough on his ACT to gain admission to his first choice of colleges.

The future: rehabilitation from autism

I hope one day that many other families will face the same dilemma of helping their child recover from autism symptoms. With proper screening and treatment for vector-borne infections, our education system will need to redefine its services for these children.

New school programs will be required to help recovering children, a type of rehabilitation, if you will. Much like someone might need intensive occupational therapy to learn to walk again after a car accident, those recovering from autism and brain inflammation will need rehabilitation as well.

Imagine if our country could move away from Applied Behavioral Analysis therapy (ABA – designed to increase social abilities like completing tasks, communicating, and learning new skills). Currently, demand for this therapy is so high that young children must often wait years to learn basic language, coping and hygiene skills. Instead, we could enter a new era in which our children are taught to catch up in their schooling and how to refine more advanced social skills.

Therapists would need to develop new programs and be specially trained to help our recovering autistic children become the adults they were meant to be.

And of course, with proper screening and treatment prior to, or in worst case, during pregnancy, hopefully the rates of autism will see a steady decline.

I look forward to this day with great anticipation. I believe it’s not a matter of if, but a matter of when.

What’s needed

There are important steps needed to make this dream a reality:

1) CDC recognition of this important medical cause of autism symptoms,

2) development of effective diagnostic testing and an extensive, flexible set of criteria for a doctor to make a clinical diagnosis of tick-borne diseases,

3) development of effective, reliable and fast-acting treatments for tick-borne diseases.

We need to call on the CDC and government to treat autism as the public health emergency it is. We must screen the 7 million cases of autism to identify those who’ve been impacted by Bartonella and Lyme-related infections. The CDC needs to work more aggressively, beyond the genetic research, to follow the path of a potential infectious cause of symptoms. Bartonella should be at the top of the list.

And of course, infected parents and siblings would need to be screened and treated too.

I say all of this with much love and acceptance to all on the autism spectrum. To our autistic teens and adults, we accept and appreciate who you are. It is okay to acknowledge that you may be sick through no fault of your own. And it’s okay to get treated, so you feel better. It could change your life.

To find a doctor to screen your child for tick-borne diseases, see LymeDisease.org’s Physician Directory or your state’s Lyme Facebook group.

Debbie Kimberg can be contacted through her website.  You can follow her son’s wellness journey on Instagram and TikTok at @hijackedbrains.

Disclaimer: The author is not a doctor. This article is the opinion of the author and is not intended to dispense medical advice. Please seek a doctor’s advice for diagnosis and treatment.

For more:

Molecular Detection of Bartonellosis

https://wwwnc.cdc.gov/eid/article/29/3/22-1223_article

Bartonella spp. Infections Identified by Molecular Methods, United States

David W. McCormick, Sara L. Rassoulian-Barrett, Daniel R. Hoogestraat, Stephen J. Salipante, Dhruba SenGupta, Elizabeth A. Dietrich, Brad T. Cookson, Grace E. Marx1Comments to Author , and Joshua A. Lieberman1
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (D.W. McCormick, E.A. Dietrich, G.E. Marx)University of Washington, Seattle, Washington, USA (S.L. Rassoulian-Barrett, D.R. Hoogestraat, S.J. Salipante, D. SenGupta, B.T. Cookson, J.A. Lieberman)
March, 2023

Abstract

Molecular methods can enable rapid identification of Bartonella spp. infections, which are difficult to diagnose by using culture or serology. We analyzed clinical test results of PCR that targeted bacterial 16S rRNA hypervariable V1–V2 regions only or in parallel with PCR of Bartonella-specific ribC gene. We identified 430 clinical specimens infected with Bartonella spp. from 420 patients in the United States. Median patient age was 37 (range 1–79) years; 62% were male.

We identified:

  • B. henselae in 77%
  • B. quintana in 13%
  • B. clarridgeiae in 1%
  • B. vinsonii in 1%
  • B. washoensis in 1% of specimens
  • B. quintana was detected in 83% of cardiac specimens
  • B. henselae was detected in 34% of lymph node specimens

We detected novel or uncommon Bartonella spp. in 9 patients. Molecular diagnostic testing can identify Bartonella spp. infections, including uncommon and undescribed species, and might be particularly useful for patients who have culture-negative endocarditis or lymphadenitis.

______________

Currently, 12 species of Bartonella genus are associated with human infection, but that number is constantly changing. Because Bartonella spp. infections are not nationally notifiable diseases, there is limited knowledge of the epidemiology of this disease in the US.  In my experience it is prolific.

For more:

Update on Young Man With Autism/Bartonella/Lyme

I love stories like these.  This is an update from this earlier post.

https://www.lymedisease.org/80-percent-improvement-autism/

After 80% improvement in autism symptoms, he’s going to college

By Debbie Kimberg

Sammy, my 18 year old, autistic son, showed an 80% improvement in autism symptoms after being diagnosed with and treated for Bartonella, Babesia, and Lyme–all included under Pediatric Acute Neuropsychiatric Syndrome or PANS.

You can find more details in my previous blog: Treating Bartonella Cleared Most of My Son’s Symptoms of Autism

An amazing event happened during the holidays last month. Sammy was accepted to a four-year university! This would have been unthinkable two years ago when we expected him to go directly on disability after high school.

My husband and I are incredibly grateful to our doctors, this community, and proud of all the hard work Sammy put in to catch up on learning he missed throughout his schooling. I hope you’ll enjoy this short video about his college acceptance! InstagramTikTokYouTube (optimized for mobile).

Looking back on our journey, one of the frustrations that I experienced was how long it took to get the correct diagnosis and treatment.

The search for root causes

When a child develops psychiatric symptoms, it can be hard to find a physician who will explore underlying medical causes such as infections. Instead, doctors are more likely to prescribe a litany of psychiatric medications.

Additionally, even if you have a doctor who is familiar with infectious causes of neuropsychiatric symptoms, it can be extremely difficult to figure out which infections in particular are the source of the problem.

For example, if your child tests positive for strep antibodies, a provider might give a diagnosis of PANS, Pediatric Autoimmune Neuropsychiatric Syndrome. But strep may not be the whole story. If you dig deeper, other infections such as Bartonella and Lyme disease may be causing the immune system to malfunction.

PANS specialists often limit their focus to common childhood infections such as strep, Epstein-Barr virus, mycoplasma pneumonia, HHV-6, cytomegalovirus and coxsackie virus.

Failing to recognize the role of Lyme and other vector-borne diseases may lead to many failed treatments, lost years of childhood, and unnecessary medical expenses.

Vector-borne diseases

For years, we worked with doctors who missed the true underlying cause of my son’s PANS symptoms by focusing primarily on strep and coxsackie infections, due to false negative vector-borne diseases (VBD) test results.

VBDs include Bartonella, Borrelia (Lyme disease), Babesia, Ehrlichia, Anaplasma, and tick-borne relapsing fever, among others. In addition to ticks, Bartonella can be transmitted by the scratch of a cat or other animal, as well as by lice, mites, bed bugs, fleas, and spiders (1). The combination of infections is often referred to as VBDs.

A PANS focus on the simple infections tested by common labs led to many failed treatments and an additional seven lost years for my son.

Unfortunately, many lab tests can give false negative test results for VBDs. That’s when it’s essential to have a knowledgeable practitioner who can give a clinical diagnosis — based on signs, symptoms and medical history.

It wasn’t until we received a clinical diagnosis for Bartonella, Babesia, and Lyme and found effective treatments, that we made true progress. With proper treatment for VBDs, my son’s strep and coxsackie virus titers returned to normal and appeared to cause no symptoms.

Dr. Amy Offutt, the president-elect of ILADS, said,“High antibodies to infections such as strep, EBV, HHV-6 and coxsackie virus can ebb and flow over time, depending on severity of symptoms, and can simply be a sign of immune dysregulation.”

What you should know

1. Congenital Bartonella and other vector-borne diseases can cause PANS symptoms. Bartonella, in particular, can cause many of the neuropsychiatric symptoms associated with PANS (2). For us, Bartonella was the most important, but not the only culprit of this story.

2. VBDs are often difficult to pick up on testing, even from specialty labs. According to Dr. Offutt, “The combination of patient and family history, clinical presentation, high suspicion, and lab results must all be considered in determining a clinical diagnosis. The more children in a family who have symptoms, the more important it is to be screened for VBDs, as well as mycotoxin/mold illness.

3. Frequently, but not always, children with VBDs have chronic illness, and not necessarily an acute presentation. Often children with chronic illness display symptoms by age four. In some adolescents, in particular girls, neuropsychiatric symptoms may not develop until late teens or early twenties (3).

Children may present with chronic symptoms such as headaches, ADHD, autism, tics, learning differences, motor delays, or sensory sensitivity prior to a final insult (i.e. illness, major stressor, or other challenge to the immune system) that can cause a sudden escalation in symptoms.

In other cases, the child has no PANS symptoms prior to an insult to the immune system which brings on an acute onset of neuropsychiatric and physical symptoms. There are reports of acute PANS cases beginning after COVID (4,5) that have been determined to be caused by a latent Bartonella infection becoming active for the first time.

Similarly, it may be possible that other infections such as strep, flu, and EBV may also cause Bartonella and other VBD activation, though research is needed to better understand this. Dr. Offutt advises that “All children suffering with neuropsychiatric issues, whether acute or chronic, should be evaluated for the possibility of a chronic vector-borne disease.”

4. Frequently, children with VBDs also have high antibodies for infections associated with more traditional PANS, such as strep, mycoplasma pneumonia, EBV, HHV-6, cytomegalovirus, influenza, and coxsackie virus. Additionally, these children may also test positive for autoimmune encephalitis, high cytokines, high interleukins, and have positive Cunningham panels. (This is a blood test which measures the levels of circulating autoantibodies associated with certain neurologic and psychiatric symptoms.)

Per Dr. Offutt, “Because high antibodies may actually be a sign of immune dysregulation, treatment for Bartonella, Babesia, Borrelia, and other vector-borne infections, if present, may resolve the immune dysfunction and should be a top priority to treat.”

Moreover, it is critical to note that treatments for VBD are different from treatments for simple PANS infections. To clear chronic VBDs, specific, complex, targeted treatments are required. If treatment for simple PANS infections prove unsuccessful, VBDs should be evaluated and clinically diagnosed, if appropriate.

VBD symptoms in children

Note: the majority of psychiatric symptoms can be caused by Bartonella. In fact, Dr. Edward Breitschwerdt, Dr. Tania Dempsey, and Dr. Daniel Kinderlehrer all have noted in their writing and webinars that Bartonella is a cause of PANS (6,7,8,9).

B – Indicates symptoms caused by Bartonella

B+ – Indicates Bartonella symptoms that may have overlapping symptoms with other VBDs

X – Vector-borne infections other than Bartonella

Symptoms Vector-borne Disease
ADHD B+
Autism Spectrum Disorder (ASD) B+
OCD B+
Oppositional Defiant Disorder (ODD) B+
Anxiety, social anxiety, separation anxiety B+
Depression B+
Antisocial B+
Mood swings/bipolar B+
Panic attacks B+
Explosive temper/irritability B+
Mood swings B+
Fears B+
Emotional lability B+
Psychosis B+
Hallucinations B+
Suicidal ideation B+
Violence B
Learning disability, low reading comprehension B
Brain fog, memory issues B+
Vocal and movement tics B
Baby talk, age regression B
Anorexia/eating disorders B+
Bedwetting/urinary issues B+
Picky eating X
Dilated eyes X
Dysgraphia X
Dyslexia X
Night terrors X
Remitting fever B+
Rashes B+
POTS B+
Digestion issues (i.e Reflux, pain) B+
Constipation or Diarrhea X
Histamine issues/Mast Cell Activation Syndrome (MCAS) B+
Seizures B

But my child wasn’t bitten by a tick or other vector?

Most people infected with VBDs do not recall a tick or insect bite. Additionally, infections can be transmitted congenitally to the child during pregnancy, often by a mother who didn’t know she was infected (10). There are a wide variety of mild to moderate symptoms of VBDs beyond chronic fatigue and pain that get little attention.

To learn more about congenital transmission and symptoms in parents, please read Do Lyme symptoms in mothers lead to ASD? for a discussion on this topic. Note: this article applies to all parents whose children have a PANS diagnosis.

What are the similarities and differences in treatment?

Treatments for strep, EBV, and other non-VBD PANS infections often involve azithromycin, augmentin, amoxicillin, or minocycline. Since these antibiotics are commonly used to treat VBDs in combination with other antibiotics, they may help a patient see some improvement in symptoms.

However, these drugs generally only treat cellular or intracellular infections. Treating VBDs require addressing all forms of the infection: cellular, intracellular, and importantly, biofilm-contained pathogens in order to see long-lasting results. Furthermore, if a child is infected with a parasitic infection such as Babesia, antimalarial drugs may be required.

Without a full understanding of what you are treating, you may experience temporary improvements, but the vector-borne infections may continue to grow and wreak havoc for the patient.

What do I do if my child isn’t improving?

I read posts on the PANDAS/PANS Facebook groups every week. Many moms are frustrated with their children’s lack of progress. They try to crowdsource advice on neuropsychiatric medications and better supplements because their children have flared or aren’t responding to treatments after years of trying. Some children are in dire straits with psychosis, severe oppositional behavior, OCD, suicidal thoughts, or aggression.

Sometimes the child has a VBD diagnosis, but the doctor missed the clinical diagnosis of Bartonella or other infections if the testing was negative. Other times, the child has the correct diagnosis including Bartonella, but is only receiving single antibiotics to treat strep and other simple infections.

In this case, the doctors are not following protocols for the targeted treatment of Bartonella and other VBDs, which may be the primary infections.

And, many other times, the child sees a traditional PANS doctor who missed the most important factors causing their patient’s neuropsychiatric symptoms.

We need all of our PANS doctors to treat VBDs

If you are a doctor who treats PANS infections without considering VBDs, as a parent who suffered through failed treatments, wasted tens of thousands of dollars, and lost years of my son’s life, I recommend two options.

1. Get trained on the full range of infections associated with VBDs, or

2. Be willing to refer PANS patients to providers who know how to screen for and treat VBDs.

We need more doctors who know how to properly diagnose and treat this complex condition!

It’s time to put the focus on Bartonella and VBDs

So many families struggle to make sense of the tests and do their best to follow the complicated treatments. To build consistency in how the disease is diagnosed and treated, doctors should provide a specific, clear, and accurate diagnosis of the primary infections.

A VBD diagnosis should not be muddled with umbrella terms like PANS. It’s time to abandon the term PANS for describing VBD and get serious about the Bartonella, Babesia, Lyme, and related infections that are stealing our children’s lives.

If your child needs an evaluation for VBD, you can find a Lyme specialist on LymeDisease.org or in your state’s Lyme Facebook groups.

If you are a doctor who wants to become a Lyme specialist or to stay abreast of the latest developments in diagnostics and treatment, contact the International Lyme and Associated Disease Society (ILADS) for educational opportunities.

The author can be contacted at debbiekimberg.com. You can follow her son’s wellness journey on Instagram and TikTok at @hijackedbrains.

References

1 Human Bartonellosis: An Underappreciated Public Health Problem?, Mercedes A. Cheslock and Monica E. Embers
2 Recovery from Lyme Disease: An Integrative Medicine Guide to Diagnosing and Treating Tick-borne Illness by Dr. Daniel A. Kinderlehrer, pages 66-77, 122-124, 131-134, 138
3 Jane Marke, MD: Tick-borne disease, Lyme, and Psychiatric Illness
4 Psychology Today: What can Lyme Disease Teach Us About Long-haul COVID, Dr. Daniel A. Kinderlehrer
5 Long COVID or Post-acute Sequelae of COVID-19 (PASC) – An Overview of Biological Factors That May Contribute to Persistent Symptoms
6 Ed Breitschwerdt, DVM; Bartonella Bacteremia and Neuropsychiatric Illnesses. 2021 LDA CME Conf., 2 Oct. 2021.
7 Why Bartonella is the New Lyme Disease, Dr. Tania Dempsey
8 Colorado Lyme and TBD Support Group Dec 5, 2021 meetup, Dr. Daniel Kinderlehrer
9 Project Lyme: Examining Bartonella, Dr. Joseph Burrascano
10 Molecular evidence of Perinatal Transmission of Bartonella vinsonii susp. berkhoffii and Bartonella henselae to a Child

Additional Resources

MothersAgainstLyme.org

Breitschwerdt explains what’s known and unknown about Bartonella, April 3, 2019

Disclaimer: The author is not a doctor. This article is the opinion of the author and is not intended to dispense medical advice. Please seek a doctor’s advice for diagnosis and treatment.